-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Rv3AnLaL+XbLqP+1ONnw+hLYKmZKEnk1SsmAMyAFuD599UzmtmMICKLLiE9b5bd+ 2Auf3Ah54XL6bWbhqoiyTw== 0000889812-98-000435.txt : 19980218 0000889812-98-000435.hdr.sgml : 19980218 ACCESSION NUMBER: 0000889812-98-000435 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980213 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDIMMUNE INC /DE CENTRAL INDEX KEY: 0000873591 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 521555759 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-42057 FILM NUMBER: 98538434 BUSINESS ADDRESS: STREET 1: 35 W WATKINS MILL RD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 3014170770 MAIL ADDRESS: STREET 1: 35 W WATKINS MILL ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: RELIANCE FINANCIAL SERVICES CORP CENTRAL INDEX KEY: 0000083047 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 510113548 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: PARK AVE PLZ STREET 2: 55 E 52ND ST 29TH FL CITY: NEW YORK STATE: NY ZIP: 10055 BUSINESS PHONE: 2129091100 MAIL ADDRESS: STREET 1: PARK AVENUE PLAZA STREET 2: 55 EAST 52ND STREET CITY: NEW YORK STATE: NY ZIP: 10055 FORMER COMPANY: FORMER CONFORMED NAME: LEASCO FINANCIAL SERVICES CORP DATE OF NAME CHANGE: 19740414 SC 13G/A 1 AMENDMENT NO. 1 TO STATEMENT OF BENEFICIAL OWNERSHIP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* --- MEDIMMUNE, INC. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, Par Value $0.01 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 584699102 -------------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 584699102 13G Page 2 of 5 Pages ----------- ---- ---- 1. NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Reliance Financial Services Corporation I.R.S. Employer Identification No.: 51-0113548 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5. SOLE VOTING POWER 508,130 (See Note 1) NUMBER OF SHARES 6. SHARED VOTING POWER BENEFICIALLY OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE POWER PERSON WITH 508,130 (See Note l) 8. SHARED DISPOSITIVE POWER 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 508,130 (See Note l ) 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 2.1% (See Note l ) 12. TYPE OF REPORTING PERSON* HC *SEE INSTRUCTION BEFORE FILLING OUT! Item 1(a) Name of Issuer: MedImmune, Inc. ................................................................... Item 1(b) Address of Issuer's Principal Executive Offices: 35 West Watkins Mill Road, Gaithersburg, MD 20878 ................................................................... Item 2(a) Name of Person Filing: Reliance Financial Services Corporation ................................................................... Item 2(b) Address of Principal Business Office or, if none, Residence: Park Avenue Plaza, 55 East 52nd Street, New York, NY 10055 ................................................................... Item 2(c) Citizenship: Delaware ................................................................... Item 2(d) Title of Class of Securities: Common Stock, Par Value $0.01 ................................................................... Item 2(e) CUSIP Number: 584699102 ................................................................... Item 3 (g) [X ] Parent Holding Company, in accordance with Section 240.13d-1(b) (ii)(G) Item 4. Ownership. (a) Amount Beneficially Owned As of December 3l, l997 508,130 (See Note l) ................................................................... (b) Percent of Class: 2.1% (See Notes l and Item 5) ................................................................... (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote 508,130 (See Note l) ................................................................... (ii) shared power to vote or to direct the vote -0- ................................................................... (iii) sole power to dispose or to direct the disposition of 508,130 (See Note l) ................................................................... (iv) shared power to dispose or to direct the disposition of -0- ................................................................... Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X] ................................................................... Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not Applicable ................................................................... Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company. Reliance Insurance Company ................................................................... Item 8. Identification and Classification of Members of the Group. Not Applicable ................................................................... Item 9. Notice of Dissolution of Group. Not Applicable ................................................................... Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 13, 1998 as of December 31, 1997 .................................................................... Date RELIANCE FINANCIAL SERVICES CORPORATION By:/s/ James E. Yacobucci ---------------------- James E. Yacobucci Senior Vice President-Investments Note 1. At December 31, 1997, Reliance Insurance Company ("RIC") beneficially owned 10,000,000 principal amount of 7% Convertible Subordinated Notes due 2003 of MedImmune, Inc. (the "Notes"), each $1,000 principal amount of which is convertible into 50.813 shares of Common Stock. Upon conversion, the Notes will total 508,130 shares of Common Stock and represent 2.1% of the Securities outstanding. -----END PRIVACY-ENHANCED MESSAGE-----